1121 related articles for article (PubMed ID: 25296715)
1. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
2. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
3. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X
J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
6. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
7. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
8. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
9. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
10. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
12. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X
Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183
[TBL] [Abstract][Full Text] [Related]
13. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
14. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
[TBL] [Abstract][Full Text] [Related]
16. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
Ji H; Sang M; Liu F; Ai N; Geng C
Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
[TBL] [Abstract][Full Text] [Related]
17. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
Tan J; Qiu K; Li M; Liang Y
FEBS Lett; 2015 Oct; 589(20 Pt B):3175-81. PubMed ID: 26318860
[TBL] [Abstract][Full Text] [Related]
18. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
19. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
[TBL] [Abstract][Full Text] [Related]
20. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
